...
首页> 外文期刊>Saudi Pharmaceutical Journal >Kawasaki disease with Glucose-6-Phosphate Dehydrogenase deficiency, case report
【24h】

Kawasaki disease with Glucose-6-Phosphate Dehydrogenase deficiency, case report

机译:川崎病伴葡萄糖6-磷酸脱氢酶缺乏症,病例报告

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Kawasaki disease (KD) is an acute, self-limited vasculitis of unknown etiology that occurs predominantly in infants and children younger than 5years of age. Coronary artery abnormalities are the most serious complication. Based on the literatures infusion of Intravenous Immunoglobulin of 2g/kg and a high dose of oral aspirin up to 100mg/kg/day are the standard treatment for Kawasaki disease in the acute stage, and should be followed by antiplatelet dose of aspirin for thrombocytosis. Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is an inherited X-linked hereditary disorder, and aspirin can induce hemolysis in patients with G6PD deficiency. We report a case of a 5year and 8month old male with KD and G6PD deficiency.
机译:川崎病(KD)是一种病因不明的急性自限性血管炎,主要发生在5岁以下的婴儿和儿童中。冠状动脉异常是最严重的并发症。根据文献,在急性期,川崎病的标准治疗方法是静脉注射2g / kg的静脉免疫球蛋白和最高100mg / kg /天的高剂量口服阿司匹林,随后应使用抗血小板剂量的阿司匹林治疗血小板增多症。葡萄糖6磷酸脱氢酶(G6PD)缺乏症是遗传性X连锁遗传性疾病,阿司匹林可引起G6PD缺乏症患者溶血。我们报告了一例5岁和8个月大的男性,患有KD和G6PD缺乏症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号